Payton is the Co-founder, Chair & Chief Executive Officer of Numinus, a company that empowers people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. He has a deep understanding of the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple therapy modalities. Suffering from severe chronic pain and auto-immune issues from birth, along with PTSD, compelled Payton to seek out psychedelics, which he attributes to saving his life. A recognized innovator and visionary in mental health care, Payton guides teams at Numinus through strategy, innovation, research and clinic network expansion, and supports the marketing and capital markets functions.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.